title: The end of the road for dual renin-angiotensin system blockade in diabetic nephropathy: which way now?
authors.affiliation: Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada. Electronic address: advania@smh.ca.
authors.forename: Andrew
authors.initials: A
authors.lastname: Advani
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced; D000419:Albuminuria / Q000188:drug therapy*; D057912:Angiotensin II Type 2 Receptor Blockers / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000075202:Contraindications; D003928:Diabetic Nephropathies / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D007022:Hypotension / Q000139:chemically induced; D016032:Randomized Controlled Trials as Topic; D012084:Renin-Angiotensin System / Q000187:drug effects*; D017211:Treatment Failure
chemical_list: D057912:Angiotensin II Type 2 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors